These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock. Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use. Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250 [TBL] [Abstract][Full Text] [Related]
7. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3): protocol for a phase III, double-blind, randomised controlled trial. Chawla LS; Russell JA; Bagshaw SM; Shaw AD; Goldstein SL; Fink MP; Tidmarsh GF Crit Care Resusc; 2017 Mar; 19(1):43-49. PubMed ID: 28215131 [TBL] [Abstract][Full Text] [Related]
10. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin. Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II for the Treatment of Vasodilatory Shock. Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM; N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561 [TBL] [Abstract][Full Text] [Related]
12. How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review. Semedi BP; Rehatta NM; Soetjipto S; Nugraha J; Mahyuddin MH; Arnindita JN; Wairooy NAP Open Access Emerg Med; 2023; 15():1-11. PubMed ID: 36636460 [TBL] [Abstract][Full Text] [Related]
13. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study. Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152 [TBL] [Abstract][Full Text] [Related]
14. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock. Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016 [TBL] [Abstract][Full Text] [Related]
15. Vasopressor therapy in critically ill patients with shock. Russell JA Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370 [TBL] [Abstract][Full Text] [Related]
16. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature. Busse LW; McCurdy MT; Ali O; Hall A; Chen H; Ostermann M Crit Care; 2017 Dec; 21(1):324. PubMed ID: 29282149 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors. Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II in septic shock. Jadhav AP; Sadaka FG Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support. Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274 [No Abstract] [Full Text] [Related]
20. The Role of Angiotensin II in Poisoning-Induced Shock-a Review. Chen A; Wong A J Med Toxicol; 2022 Apr; 18(2):145-154. PubMed ID: 35258848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]